TLR4 rs4986790: What Your Genotype Means
The rs4986790 variant is a specific genetic change in the TLR4 gene that alters the structure of a key immune receptor. It is associated with variations in how the body recognizes and responds to certain bacterial and viral pathogens.
What each genotype means
Typical immune receptor function
This is the most common genotype for this variant, often considered the reference or wild-type sequence. Research suggests this version of the TLR4 receptor functions as expected in identifying pathogens and initiating immune responses.
Carried by the vast majority of individuals globally, though frequencies vary by ancestry.
Altered immune receptor signaling
Carrying one copy of the G allele may influence how your TLR4 receptor responds to certain bacterial components and endotoxins. Studies have shown mixed results regarding disease susceptibility, with some evidence suggesting potential differences in immune response or inflammatory signaling compared to the AA genotype.
This heterozygous genotype is found in a minority of the population, with higher prevalence in some European groups.
Reduced immune receptor sensitivity
This genotype, sometimes referred to as the Asp299Gly variant, is associated with reduced cell-surface expression of the TLR4 receptor and a potentially diminished pro-inflammatory cytokine response to specific bacterial triggers. While some research links this to altered susceptibility to various infectious and inflammatory conditions, results are often conflicting and highly dependent on the specific disease and population studied.
This is the least common genotype, occurring in a small percentage of individuals, primarily within European populations.
Understanding the rs4986790 Variant
The rs4986790 variant, often referred to as Asp299Gly or 896A/G, is a single nucleotide polymorphism (SNP) located within the third exon of the TLR4 gene. At the molecular level, this variant involves a substitution of an adenine (A) base for a guanine (G) base at position 896. This specific change results in a missense mutation, where the amino acid aspartic acid is replaced by glycine at the 299th position of the TLR4 protein. Because this site is located within the extracellular ligand-binding domain of the receptor, the structural change can influence how the protein interacts with external signals. This variant is a well-studied example of how a single letter change in the genetic code can potentially impact the functional architecture of a protein involved in the human immune system.
The Role of the TLR4 Gene
The TLR4 gene encodes the Toll-like receptor 4 protein, which is a critical component of the innate immune system. TLR4 acts as a sensor that detects lipopolysaccharides (LPS), which are molecules found on the outer membranes of many Gram-negative bacteria. When TLR4 recognizes these pathogens, it initiates a signaling cascade—often involving proteins like MyD88 and TRIF—that triggers the production of pro-inflammatory cytokines. This process is essential for alerting the body to the presence of an infection and coordinating an immune defense. Because TLR4 is a primary gatekeeper for detecting bacterial threats, any structural modification to this receptor, such as the one caused by rs4986790, may lead to altered signaling efficiency. Research suggests that this variant can impair the recruitment of downstream signaling molecules, potentially leading to a diminished or modified inflammatory response when the receptor is activated.
Research and Clinical Associations
Scientific research has investigated the association between rs4986790 and various infectious diseases, with evidence strength generally considered moderate. Studies have linked the G allele to an increased susceptibility to certain bacterial infections, particularly those caused by Gram-negative bacteria, as well as chronic viral infections like HBV and HCV. The functional impact of this variant is complex; while some studies suggest it may lead to a dampened immune response, other research has explored its role in modulating the severity of inflammatory conditions. For instance, some data indicates that individuals carrying the G allele might experience different outcomes in response to COVID-19 or vaccination, with some reports suggesting a potential protective effect against severe hospitalization in specific cohorts. Because these findings are often context-dependent and vary across different populations and disease models, the clinical significance of this variant remains a subject of ongoing investigation rather than a definitive diagnostic marker.
Population Frequency
The rs4986790 variant is most commonly observed in populations of European ancestry, where the minor allele frequency is approximately 5%. Its prevalence can vary significantly across different global populations, and it is less common in many other ethnic groups. Understanding these frequency differences is important for researchers studying the evolutionary history of immune-related genes and for interpreting genetic data in diverse clinical settings.
Interpreting Your Genetic Information
If you have information about your rs4986790 genotype, it is important to view it as a piece of statistical data rather than a medical diagnosis. Genetic associations are based on population-level trends and do not predict individual health outcomes with certainty. Many factors, including environmental exposures, overall health, and other genetic variants, contribute to how your immune system functions. You cannot use this information to self-diagnose or determine your personal risk for specific infections. If you have concerns about your immune health, susceptibility to infections, or how your genetics might influence your response to medications or vaccines, you should discuss these topics with a qualified healthcare provider or a clinical geneticist. They can provide context based on your full medical history and help you understand what, if any, clinical steps are appropriate for your specific situation.
How common is this variant?
The rs4986790 variant is found in approximately 5% of individuals of European descent, with varying frequencies observed across other global populations.
Frequently asked questions
What does the TLR4 rs4986790 variant do?
The rs4986790 variant causes a structural change in the TLR4 protein, which is a receptor that helps the immune system detect bacteria. This change can lead to less efficient signaling when the receptor is activated by pathogens.
Does having the G allele mean I have a weak immune system?
Not necessarily. While the variant is associated with altered immune signaling in research studies, it does not mean an individual has a generally 'weak' immune system. Immune function is highly complex and influenced by many different genes and environmental factors.
Is rs4986790 linked to COVID-19 outcomes?
Some research has explored the relationship between this variant and COVID-19, with some studies suggesting potential differences in disease severity or vaccine response. However, these findings are based on specific cohorts and are not universal.
Should I get tested for this variant?
There is no standard clinical recommendation to test for this variant for general health purposes. Genetic testing should be discussed with a healthcare provider if there is a specific medical reason to investigate your immune response.
Sources & further reading
Educational information only, last refreshed 10/2/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4986790?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TLR4
While historically investigated for age-related macular degeneration (AMD) risk, current meta-analyses indicate inconsistent results; rs2111902 lacks robust, replicated clinical validation for this trait.
Missense alteration (p.Thr399Ile) in toll-like receptor 4 disrupting lipopolysaccharide signaling and modifying gram-negative sepsis susceptibility.
Variant near TLR4 linked in longevity GWAS with exceptional survival past age 90 through innate immune regulation.
This SNP in the TLR4 gene is associated with an increased risk for chorionic plate inflammation during pregnancy.